Similar articles for PMID: 26634688

Year	Number of Results
1980	1
1998	1
1999	1
2000	1
2001	1
2002	3
2003	3
2004	3
2005	4
2006	2
2007	4
2008	2
2009	3
2010	2
2011	2
2012	5
2013	6
2014	4
2015	18
2016	5
2017	10
2018	7
2019	3
2020	7
2021	5
2022	2
2024	0

1

Future mechanistic strategies for tackling fibrosis--an unmet need in liver disease.

Fallowfield JA. Fallowfield JA. Clin Med (Lond). 2015 Dec;15 Suppl 6:s83-7. doi: 10.7861/clinmedicine.15-6-s83. Clin Med (Lond). 2015. PMID: 26634688 Free article. Review.

2

Resolution of liver fibrosis: basic mechanisms and clinical relevance.

Ramachandran P, Iredale JP, Fallowfield JA. Ramachandran P, et al. Semin Liver Dis. 2015 May;35(2):119-31. doi: 10.1055/s-0035-1550057. Epub 2015 May 14. Semin Liver Dis. 2015. PMID: 25974898 Review.

3

Liver fibrosis: Direct antifibrotic agents and targeted therapies.

Schuppan D, Ashfaq-Khan M, Yang AT, Kim YO. Schuppan D, et al. Matrix Biol. 2018 Aug;68-69:435-451. doi: 10.1016/j.matbio.2018.04.006. Epub 2018 Apr 12. Matrix Biol. 2018. PMID: 29656147 Review.

4

Pathobiology of liver fibrosis: a translational success story.

Lee YA, Wallace MC, Friedman SL. Lee YA, et al. Gut. 2015 May;64(5):830-41. doi: 10.1136/gutjnl-2014-306842. Epub 2015 Feb 13. Gut. 2015. PMID: 25681399 Free PMC article. Review.

5

Therapeutic targets in liver fibrosis.

Fallowfield JA. Fallowfield JA. Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G709-15. doi: 10.1152/ajpgi.00451.2010. Epub 2011 Jan 13. Am J Physiol Gastrointest Liver Physiol. 2011. PMID: 21233278 Free article. Review.

6

Early to Phase II drugs currently under investigation for the treatment of liver fibrosis.

Hauff P, Gottwald U, Ocker M. Hauff P, et al. Expert Opin Investig Drugs. 2015 Mar;24(3):309-27. doi: 10.1517/13543784.2015.997874. Epub 2014 Dec 30. Expert Opin Investig Drugs. 2015. PMID: 25547844 Review.

7

Antifibrotic Therapies: Where Are We Now?

Yoon YJ, Friedman SL, Lee YA. Yoon YJ, et al. Semin Liver Dis. 2016 Feb;36(1):87-98. doi: 10.1055/s-0036-1571295. Epub 2016 Feb 12. Semin Liver Dis. 2016. PMID: 26870935 Review.

8

Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression.

Caligiuri A, Gentilini A, Pastore M, Gitto S, Marra F. Caligiuri A, et al. Cells. 2021 Oct 15;10(10):2759. doi: 10.3390/cells10102759. Cells. 2021. PMID: 34685739 Free PMC article. Review.

9

Hepatitis C and liver fibrosis.

Schuppan D, Krebs A, Bauer M, Hahn EG. Schuppan D, et al. Cell Death Differ. 2003 Jan;10 Suppl 1:S59-67. doi: 10.1038/sj.cdd.4401163. Cell Death Differ. 2003. PMID: 12655347 Review.

10

Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Sepulveda-Crespo D, Resino S, Martinez I. Sepulveda-Crespo D, et al. Drugs. 2021 Mar;81(4):419-443. doi: 10.1007/s40265-020-01458-x. Drugs. 2021. PMID: 33400242 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year